Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

rufloxacin

Known as: 9-fluoro-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]thiazino[2,3,4-ij]quinoline-6-carboxylic acid, 9-fluoro-10-(N-(4'-methyl)piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido(1,2,3de)-1,4-benzothiazine-6-carboxylic acid 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
ABSTRACT Bacterial keratitis is a serious infectious ocular disease requiring prompt treatment to prevent frequent and severe… Expand
Highly Cited
2004
Highly Cited
2004
Our aim was to compare weekly rufloxacin with daily norfloxacin in the secondary prophylaxis of spontaneous bacterial peritonitis… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2004
Highly Cited
2004
ABSTRACT We investigated the in vitro effects of seven fluoroquinolones (ciprofloxacin, grepafloxacin, levofloxacin, moxifloxacin… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2003
2003
Photodegradation of ofloxacin (OFX) under aerobic conditions gives rise to N-demethylation, mainly involving coupling of radical… Expand
2002
2002
The role played by type I (radical) and type II (singlet oxygen) mechanisms in the Rufloxacin (RFX)-photoinduced production of 8… Expand
1999
1999
Abstract The UVA irradiation of 9‐fluoro‐2,3‐dihydro‐10‐4′‐meth‐yl‐l'‐piperazinyl‐7‐oxo‐7H‐pyrido[l,2,3‐de]‐l,4‐benzo‐thiazine‐6… Expand
1995
1995
PURPOSE We compare the bacteriological and clinical efficacy of rufloxacin and ciprofloxacin in patients with acute uncomplicated… Expand
1992
1992
The in-vitro activity of two new quinolone antimicrobials, rufloxacin and MF 961, together with the desmethylated metabolite of… Expand
1992
1992
The pharmacokinetics and safety of rufloxacin were evaluated in a double-blind, placebo-controlled study. Two groups of 16… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
1991
1991
Rufloxacin is a new long-acting, once-daily quinolone antibacterial agent. We evaluated inter- and intrasubject variations in… Expand
  • figure 1
  • table 1
  • figure 2